SCHEMBL16339258

SCHEMBL16339258

Cc1cn2cc(NC(=O)c3cnc(N4CCNCC4)c(C)c3)cc(F)c2n1.Cc1cn2cc(NC(=O)c3cnc(N4CCNCC4)cc3F)cc(F)c2n1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ HDAC2 Q92769 4/20 0.37
▸ HDAC3 O15379 4/20 0.37
▸ FASN P49327 1/20 0.37
▸ RAF1 P04049 2/20 0.37
▸ BRAF P15056 2/20 0.37
▸ HDAC1 Q13547 2/20 0.36
▸ HDAC10 Q969S8 1/20 0.36
▸ HDAC6 Q9UBN7 1/20 0.36
▸ IRAK4 Q9NWZ3 1/20 0.36
▸ FSCN1 Q16658 1/20 0.36
▸ IKBKE Q14164 1/20 0.36
▸ TBK1 Q9UHD2 1/20 0.36
▸ ABL1 P00519 1/20 0.36
▸ MAPK7 Q13164 1/20 0.36
▸ CLK2 P49760 1/20 0.36
▸ CLK3 P49761 1/20 0.36
▸ DYRK1A Q13627 1/20 0.36
▸ PTK6 Q13882 1/20 0.35
▸ AURKB Q96GD4 1/20 0.35
▸ KCNQ3 O43525 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17765375 0.92 HDAC3 (0.41) HDAC2HDAC3RAF1BRAFHDAC1
SCHEMBL16339537 0.92 IKBKE (0.41) HDAC2HDAC3RAF1BRAFIRAK4
SCHEMBL16339631 0.85 HDAC2 (0.51) HDAC2HDAC3FASNHDAC1HDAC10
Hydrochloric Acid SCHEMBL17765374 0.84 HDAC2 (0.50) HDAC2HDAC3FASNHDAC1HDAC10
SCHEMBL16339353 0.83 IKBKE (0.39) RAF1BRAFIRAK4FSCN1IKBKE
SCHEMBL16339445 0.81 LCK (0.41) IRAK4FSCN1IKBKETBK1MAPK7
SCHEMBL24032909 0.81 MAPK7 (0.44) HDAC2HDAC3RAF1BRAFHDAC6
SCHEMBL24033086 0.80 HDAC3 (0.52) HDAC2HDAC3HDAC1MAPK7
SCHEMBL16340026 0.79 IRAK4 (0.38) RAF1BRAFIRAK4FSCN1IKBKE
SCHEMBL25105108 0.79 IRAK4 (0.37) RAF1BRAFIRAK4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3013345-A2 COMPOUNDS FOR TREATING SPINAL MUSCULAR ATROPHY F. Hoffmann-La Roche AG (CH) 2016-05-04 — — EP disclosed
WO-2014209841-A2 COMPOUNDS FOR TREATING SPINAL MUSCULAR ATROPHY F. HOFFMANN-LA ROCHE AG (CH) 2014-12-31 — — WO disclosed
Send feedback